Company Overview and News


Add TBQBF
to your dashboard

Headline News

2018 Is The Year To Make Great Gains In Crypto And Cannabis

2018-01-16 seekingalpha
I'm excited about 2018 after coming off one of my best years in my 24 years of investing. I had a 15.93% return in my brokerage accounts and a 646% return in my crypto investments. (56-0)

2018 Is The Year To Make Great Gains In Crypto & Cannabis

2018-01-16 seekingalpha
I'm excited about 2018 after coming off one of my best years in my 24 years of investing. I had a 15.93% return in my brokerage accounts and a 646% return in my crypto investments. (56-0)

Today’s Free Reports, OrganiGram Holdings, Medifocus, Antibe Therapeutics, and Emerald Health Therapeutics

2018-01-11 accesswire
LONDON, UK / ACCESSWIRE / January 11, 2018 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: OrganiGram Holdings, Medifocus, Antibe Therapeutics, and Emerald Health Therapeutics. Access our complimentary up-to-the-minute research reports by becoming an online member now: (10-0)

Top-Performing Marijuana Stocks Of December

2017-12-28 seekingalpha
December has seen the culmination of at least 2 distinct catalysts propel several leading marijuana stocks much higher before the end of the year. (48-0)

Budding Marijuana Company In Canada

2017-12-13 seekingalpha
They have the facilities, and partner, to potentially become a major player in the North American market. (12-0)

Research Reports on OrganiGram Holdings, IntelGenx Technologies, Antibe Therapeutics, and Emerald Health Therapeutics

2017-12-07 accesswire
LONDON, UK / ACCESSWIRE / December 07, 2017 / Active-Investors free stock reports for this morning include these Toronto Exchanges' equities from the Biotechnology industry: OrganiGram Holdings, IntelGenx Technologies, Antibe Therapeutics, and Emerald Health Therapeutics. Access our complimentary up-to-the-minute research reports by becoming an online member now: (13-0)

Marijuana Stocks Ready To Turn A New Leaf In 2018

2017-12-05 seekingalpha
Those just getting their feet wet in dealing with marijuana stocks may or may not want to choose an ETF at first because risks are still present. (34-2)

Canada could make billions from legal pot - Dec. 2, 2017

2017-12-02 money.cnn
Canada's Cannabis Act was introduced in the Canadian Senate Tuesday, its last legislative stop. The bill enjoys wide public support and the backing of Prime Minister Justin Trudeau. (23-0)

Emerald Health Therapeutics Announces Positive Health Canada Review of License Application for Prominent Fourth Facility

2017-11-28 marketwired
Construction of first 75,000 square feet of new greenhouse targeted for completion in March 2018; next expansion phase to over 500,000 square feet to be completed by end 2018 (4-0)

Canadian Marijuana Stocks Have U.S. Investors Looking At F Stocks

2017-11-27 seekingalpha
For US investors, Canadian marijuana stocks may offer more opportunity while the US tries to figure out which path it wants to take for national legalization. (42-4)

Northern Vine Labs Combines the Best of Abattis and Emerald Health -- CFN Media

2017-11-22 marketwired
SEATTLE, WA--(Marketwired - Nov 22, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering the partnership between Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF) and Emerald Health Therapeutics Inc. (TSX VENTURE: EMH) (OTCQX: EMHTF) to run Northern Vine Laboratories as a joint venture, which promises to take advantage of a growing market for lab testing and extract products. (8-0)

3 Canadian Cannabis ADRs to Consider as the Sector Takes Off

2017-11-20 247wallst
Cannabis stocks are making a comeback, no thanks to US-based medical marijuana companies. The United States Marijuana Index, a collection of 17 firms, is still languishing at 55% below its 2015 highs. The Canadian Marijuana Index, on the other hand, representing another 18 firms, is up over 300% since July and is knocking on the door of all-time highs. (18-2)

CFN Media Exclusive CEO Interview: Abattis Validates Lab Strategy, Sets Stage for Rapid Growth

2017-11-06 marketwired
SEATTLE, WA--(Marketwired - Nov 6, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive executive interview with Rob Abenante, CEO of Abattis Bioceuticals Corp. (CSE: ATT) (CNSX: ATT) (CNSX: ATT.CN) (OTCQB: ATTBF). In the interview, Mr. Abenante discusses the company's cannabis testing and product development strategy in light of the recently announced partnership with Emerald Health Therapeutics. (27-0)

Emerald Health Expands Capabilities with Northern Vine Labs Deal -- CFN Media

2017-11-01 marketwired
SEATTLE, WA--(Marketwired - Nov 1, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article covering Emerald Health Therapeutics Inc.'s (TSX VENTURE: EMH) (OTCQX: EMHTF) recent deal with Abattis Bioceuticals Corp. to acquire a controlling interest in Northern Vine Labs. The agreement could grow Northern Vine into a thriving center for analytical testing, genetic research and development, tissue culture, and proprietary medicinal and therapeutic formulations. (8-1)

Emerald Health Looks to Address Canada's Cannabis Production Shortfall -- CFN Media

2017-10-24 marketwired
SEATTLE, WA--(Marketwired - Oct 24, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an article discussing Emerald Health Therapeutics (TSX VENTURE: EMH) (OTCQX: EMHTF) and its position in Canada's marijuana market. Canada's cannabis industry is projected to exceed $22.6 billion in size over the coming years as the country benefits from strong domestic and export demand. (4-0)

Stock Research Report

Emerald Health Therapeutics, Inc. was incorporated pursuant to the Business Corporations Act (British Columbia) on July 31, 2007 as Firebird Capital Partners Inc. and changed its name to Firebird Energy Inc. in December 2012. On September 4, 2014, the Company completed the acquisition of all the issued and outstanding common shares of Thunderbird Biomedical Inc. (“Thunderbird”), by way of a reverse takeover (the “Transaction”) under the rules of the TSX Venture Exchange (the “TSXV”) and concurrently changed its name to T-Bird Pharma, Inc. At that time, Thunderbird became a wholly-owned subsidiary of T-Bird. In June 2015, the Company changed its name to Emerald Health Therapeutics, Inc. and Thunderbird changed its name to Emerald Health Botanicals Inc. (“Botanicals”).

The Company is a publicly traded company with headquarters in Victoria, British Columbia, Canada. Common shares of the Company (the “Common Shares”) are listed on the TSXV under the trading symbol “EMH”. The Company is ...

Click for full article
CUSIP: 29102R106